New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 12, 2012
11:20 EDTMMI, GOOGEarnings Preview: Google's Q1 results could closely resemble Q4 numbers
Google (GOOG) is expected to report Q1 earnings after the market close on Thursday, April 12, with a conference call scheduled for 4:30 pm ET. The consensus estimate is $9.65 for EPS and $8.15B for revenue, according to First Call. Google reported weaker than expected fourth quarter results after its third quarter results beat expectations. The outlook for first quarter results is mixed, as Google's shares have pulled back a bit in the last few weeks. In fact, Google shares have slipped 1.54% this year, compared to the Nasdaq's gain of 15.79%. Last quarter, Investors were particularly concerned about an unexpected drop in prices for Google's Internet search ads. Some analysts believe the change reflects a shift to more searches on smartphones, where advertising rates are lower. Others are worried that the downturn in ad prices is a sign that Google is losing share to competitors, including Facebook (FB). Investors will be looking for clues in order to determine whether the drop in ad prices last year was an aberration or the start of a trend that could slow the company's growth. Google's Q1 expenses also are likely to be a focal point of the report, as CEO Larry Page has pledged to make expensive investments in employees and projects that he believes will boost the company's long-term returns. Analysts also will likely inquire about the status of Google's proposed $12.5B acquisition of cellphone maker Motorola Mobility Holdings (MMI). Needham's Q1 estimates are below consensus expectations, with the firm predicting that the company will be hurt by continued declines in cost-per-click, or CPC, rates and weakness in Europe. The firm expects Google to report Q1 net revenue of $8.043B and pro forma EPS of $9.26. Needham says that while the number of Google's U.S. core search queries increased 9% YoY in Q1, strong mobile growth should push overall query growth ahead of these expectations. However, the firm believes that CPC rates could decline 4%. Additionally, Needham believes that European search spending continued to slow due to the macro environment there. After conducting industry checks and evaluating YouTube trends, Nthe firm expects the growth of Google's display business to moderate in Q1. However, Needham expects advertisers to continue to allocate more of their budgets to Google, given its deep search relationships, large YouTube audience, and end-to-end display advertising ecosystem. Android activations reached 850,000 per day in Q1, Needham notes, and the operating system should continue to be the primary growth engine for Google's mobile advertising and app revenue, said the firm. Needham maintains a Buy rating on the shares with a $750 price target. Consensus estimates for Q2 and FY12 are: $10.01 on $8.43B in revenue and $42.60 on $35.45B in revenue, respectively.
News For GOOG;MMI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
January 14, 2015
12:21 EDTGOOGGoogle to launch smartphone in test market of Puerto Rico, Tech Crunch says
Subscribe for More Information
10:27 EDTGOOGFacebook, Google seen at front of 'multi-year' positive run for Internet stocks
Subscribe for More Information
09:46 EDTGOOGGoogle initiated with a Buy at Rosenblatt
Target $575.
09:36 EDTGOOGActive equity options trading
Subscribe for More Information
08:15 EDTGOOGGoogle sentiment may be overly negative, says RW Baird
Baird believes investor sentiment for Google may be overly negative, exacerbated by the accelerating shift to mobile. The firm believes that 50%-60% of Google's revenues are already coming from Mobile, Video, Local Enterprise and other segments, which removes worries about desktop dependence. Baird also noted the company's valuation is at the low end of comparable multiples, suggesting a favorable risk/reward scenario. Baird reiterated its Outperform rating and $680 price target on Google shares.
07:41 EDTGOOGGoogle risk/reward compelling, says SunTrust
Subscribe for More Information
06:29 EDTGOOGCompanies reach new deal on worker hiring issue, Reuters says
Subscribe for More Information
06:14 EDTGOOGMediaTek: Worldwide tablet shipments rise at slower pace, DigiTimes says
Subscribe for More Information
January 13, 2015
13:56 EDTGOOGGM open to partnering with Google on self-driving cars, Time says
GM (GM) would be open to having a discussion with Google (GOOG) about jointly developing self-driving cars, GM Chief Technology Officer Jon Lauckner said, according to Time Magazine. Reference Link
12:32 EDTGOOGGoogle February volatility elevated as shares rally from 14-month low
Google January call option implied volatility is at 21, January weekly is at 22, February is at 28, March is at 23; compared to its 26-week average of 22 according to Track Data, suggesting large near tem price movement.
09:36 EDTGOOGActive equity options trading
Active equity options trading according to Track Data: AAPL AMD AA TWTR GILD C CELG TSLA GOOG
January 12, 2015
13:14 EDTGOOGAnalysts take opposite sides in regards to Google shares
Subscribe for More Information
11:19 EDTGOOGGoogle set to provide real-time translation via Translate app, NY Times reports
Subscribe for More Information
10:00 EDTGOOGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:40 EDTGOOGGoogle no longer fixing older Android security flaws, WSJ reports
Subscribe for More Information
09:22 EDTGOOG23andMe announces collaboration with Pfizer
Google (GOOG)-backed 23andMe announced an agreement with Pfizer (PFE) that will provide Pfizer with access to 23andMe’s research platform, including services and Research Portal analysis of 23andMe’s genotyped population of over 800,000 individuals, of which more than 80 percent have consented to participate in research. 23andMe’s Research Portal enables qualified and approved scientists outside of 23andMe the opportunity to leverage the company’s unique research model while still protecting the privacy and security of 23andMe’s customers. As a part of the agreement, the companies will collaborate on certain genome-wide association studies, surveys, and clinical trial recruitment. One of these collaborations will be a longitudinal study to better understand the genetics of lupus. This study will entail enrollment and genotyping of 5,000 people into a new lupus research community, and include the integration of medical records, targeted bio-sampling along with genetic information for all participants. This announcement follows a collaboration between 23andMe and Pfizer to enroll 10,000 people with Inflammatory Bowel Disease in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Nearly 4,000 patients have been enrolled in the community since August 2014.
08:21 EDTGOOGApple poised to gain market share, says JMP Securities
Subscribe for More Information
08:02 EDTGOOGGoogle shares undervalued, says Bernstein
Subscribe for More Information
07:38 EDTGOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
06:46 EDTGOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use